Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.52 EUR | -4.70% | -20.83% | -0.33% |
Sales 2024 * | 10.6M 11.32M | Sales 2025 * | 6.95M 7.42M | Capitalization | 39.18M 41.83M |
---|---|---|---|---|---|
Net income 2024 * | -11M -11.75M | Net income 2025 * | -17M -18.15M | EV / Sales 2024 * | 5.3 x |
Net Debt 2024 * | 17M 18.15M | Net Debt 2025 * | 14M 14.95M | EV / Sales 2025 * | 7.65 x |
P/E ratio 2024 * |
-4.31
x | P/E ratio 2025 * |
-2.85
x | Employees | 76 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.46% |
Latest transcript on Medigene AG
1 day | -4.70% | ||
1 week | -20.83% | ||
Current month | -27.96% | ||
1 month | -35.59% | ||
3 months | +5.19% | ||
6 months | -3.18% | ||
Current year | -0.33% |
Managers | Title | Age | Since |
---|---|---|---|
Selwyn Ho
CEO | Chief Executive Officer | 53 | 22-07-24 |
Chief Tech/Sci/R&D Officer | - | 14-04-30 | |
Pamela Keck
IRC | Investor Relations Contact | - | 23-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 16-08-11 | |
Frank Mathias
BRD | Director/Board Member | 62 | 18-05-14 |
Anthony Man
BRD | Director/Board Member | 68 | 20-12-15 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.52 | -4.70% | 43 128 |
24-04-25 | 1.595 | +0.31% | 12,206 |
24-04-24 | 1.59 | -7.56% | 42,373 |
24-04-23 | 1.72 | -10.42% | 114,079 |
24-04-22 | 1.92 | 0.00% | 3,487 |
Delayed Quote Xetra, April 26, 2024 at 10:57 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.33% | 41.97M | |
-2.16% | 103B | |
+0.48% | 95.71B | |
+2.18% | 22.02B | |
-16.70% | 20.9B | |
-9.30% | 17.85B | |
-42.83% | 16.21B | |
-14.98% | 15.52B | |
+3.93% | 13.86B | |
+34.02% | 12.04B |
- Stock Market
- Equities
- MDG1 Stock